Latest news
Nuvation Bio (NUVB) Stock Rises On IBTROZI Growth And Deeper Losses - simplywall.stsimplywall.st · Sat, 08 Aug 2026 03:40:16 GMTWhy Nuvation Bio (NUVB) Is Down 8.8% After Surging Q2 2026 Revenue and IBTROZI Data Tease - simplywall.stsimplywall.st · Fri, 07 Aug 2026 12:39:51 GMTNuvation Bio Earnings Call Highlights IBTROZI Surge - TipRanksTipRanks · Fri, 07 Aug 2026 04:41:15 GMTNuvation Bio reports $31.7M Q2 revenue, IBTROZI... - PluangPluang · Thu, 06 Aug 2026 21:00:16 GMTNuvation Bio (NUVB) surges to $114.9M revenue and issues $250M notes - Stock TitanStock Titan · Thu, 06 Aug 2026 10:55:57 GMTNuvation Bio (NUVB) To Share New IBTROZI Data At Two Major Cancer Conferences - simplywall.stsimplywall.st · Wed, 05 Aug 2026 04:03:44 GMTDo IBTROZI’s TRUST Data Shape Nuvation Bio’s (NUVB) Edge in Targeted Lung Cancer Therapy? - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 16:16:18 GMTNuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses - PR NewswirePR Newswire · Tue, 04 Aug 2026 12:00:00 GMT